Scientists created a vaccine against cancer

Finnish scientists have found that tetanus vaccination positively affects the body's ability to fight cancer tumors. Using the findings, the researchers developed and tested a cancer vaccine. Cancer Research reports. Researchers at the University of Helsinki have found in mouse experiments that the vaccine-immunized body has a stronger immune response, including cancer cells that infected test mice. The very effect of immunization is that when faced with a viral, bacterial protein or toxin, immune T cells remember the structure of the pathogen and respond with a weak primary immune response. But when the pathogen appears in the body once more, T cells respond with much stronger secondary immunity and defeat the disease. Finnish researchers connected the anti-tin anatoxin to tumor proteins, thus obtaining the anti-cancer vaccine PeptiCRAd. When introduced into the body of mice vaccinated earlier from tetanus, the body of a test animal infected with cancer produced at once strong secondary immunity against the tumor and defeated oncology. Recall, the news agency reported that French scientists proposed to use safe rotavirus vaccines as an anticancer drug.